Skip to main content Accessibility help
×
Home

Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: longitudinal evidence from the National Epidemiologic Study on Alcohol and Related Conditions

  • S. S. Martins (a1), M. C. Fenton (a1), K. M. Keyes (a1), C. Blanco (a1), H. Zhu (a1) and C. L. Storr (a1)...

Abstract

Background

Non-medical use of prescription opioids represents a national public health concern of growing importance. Mood and anxiety disorders are highly associated with non-medical prescription opioid use. The authors examined longitudinal associations between non-medical prescription opioid use and opioid disorder due to non-medical opioid use and mood/anxiety disorders in a national sample, examining evidence for precipitation, self-medication and general shared vulnerability as pathways between disorders.

Method

Data were drawn from face-to-face surveys of 34 653 adult participants in waves 1 and 2 of the National Epidemiologic Survey on Alcohol and Related Conditions. Logistic regression models explored the temporal sequence and evidence for the hypothesized pathways.

Results

Baseline lifetime non-medical prescription opioid use was associated with incidence of any mood disorder, major depressive disorder (MDD), bipolar disorder, any anxiety disorder and generalized anxiety disorder (GAD in wave 2, adjusted for baseline demographics, other substance use, and co-morbid mood/anxiety disorders). Lifetime opioid disorder was not associated with any incident mood/anxiety disorders. All baseline lifetime mood disorders and GAD were associated with incident non-medical prescription opioid use at follow-up, adjusted for demographics, co-morbid mood/anxiety disorders, and other substance use. Baseline lifetime mood disorders, MDD, dysthymia and panic disorder were associated with incident opioid disorder due to non-medical prescription opioid use at follow-up, adjusted for the same covariates.

Conclusions

These results suggest that precipitation, self-medication as well as shared vulnerability are all viable pathways between non-medical prescription opioid use and opioid disorder due to non-medical opioid use and mood/anxiety disorders.

Copyright

Corresponding author

*Address for correspondence: S. S. Martins, Ph.D., Johns Hopkins Bloomberg School of Public Health, Department of Mental Health, 624 N. Broadway, 8th floor, Suite 896, Baltimore, MD 21205-1900, USA. (Email: smartins@jhsph.edu)

References

Hide All
APA (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. APA: Washington, DC.
Becker, WC, Sullivan, LE, Tetrault, JM, Desai, RA, Fiellin, DA (2008). Non-medical use, abuse and dependence on prescription opioids among US adults: psychiatric, medical and substance use correlates. Drug and Alcohol Dependence 94, 3847.
Blanco, C, Alderson, D, Ogburn, E, Grant, BF, Nunes, EV, Hatzenbuehler, ML, Sasin, DS (2007). Changes in the prevalence of non-medical prescription drug use and drug use disorders in the United States: 1991–1992 and 2001–2002. Drug and Alcohol Dependence 90, 252260.
Boyd, CJ, McCabe, SE (2009). Coming to terms with nonmedical use of prescription medications. Substance Abuse Treatment, Prevention and Policy 3, 22.
Brady, KT, Sinha, R (2005). Co-occurring mental and substance use disorders: the neurobiological effects of chronic stress. American Journal of Psychiatry 162, 14831493.
Brands, B, Paglia-Boak, A, Sproule, BA, Leslie, K, Adlaf, EM (2010). Nonmedical use of opioid analgesics among Ontario students. Canadian Family Physician 56, 256262.
Byrt, T (1996). How good is agreement? Epidemiology 7, 561.
Canino, G, Bravo, M, Ramirez, R, Febo, VE, Rubio-Stipec, M, Fernandez, RL, Hasin, D (1999). The Spanish Alcohol Use Disorder and Associated Disabilities Interview Schedule (AUDADIS): reliability and concordance with clinical diagnoses in a Hispanic population. Journal of Studies on Alcohol 60, 790799.
Compton, WM, Conway, KP, Stinson, FS, Colliver, JD, Grant, BF (2005 a). Prevalence and comorbidity of DSM-IV antisocial syndromes and specific drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry 66, 677685.
Compton, WM, Thomas, YF, Conway, KP, Colliver, JD (2005 b). Developments in the epidemiology of drug use and drug use disorders. American Journal of Psychiatry 162, 14941502.
Emrich, HM, Vogt, P, Herz, A (1982). Possible antidepressive effects of opioids: action of buprenorphine. Annals of the New York Academy of Sciences 398, 108112.
Fleiss, JL (1981). Statistical Methods for Rates and Proportions, 2nd edn. John Wiley and Sons: New York.
Grant, BF, Dawson, DA, Stinson, FS, Chou, PS, Kay, W, Pickering, R (2003). The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample. Drug and Alcohol Dependence 71, 7–16.
Grant, BF, Harford, TC, Dawson, DA, Chou, PS, Pickering, RP (1995). The Alcohol Use Disorder and Associated Disabilities Interview schedule (AUDADIS): reliability of alcohol and drug modules in a general population sample. Drug and Alcohol Dependence 39, 3744.
Grant, BF, Hasin, DS, Stinson, FS, Dawson, DA, Chou, SP, Ruan, WJ, Huang, B (2005). Co-occurrence of 12-month mood and anxiety disorders and personality disorders in the US: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Psychiatric Research 39, 19.
Grant, BF, Hasin, DS, Stinson, FS, Dawson, DA, Chou, SP, Ruan, WJ, Pickering, RP (2004 a). Prevalence, correlates, and disability of personality disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry 65, 948958.
Grant, BF, Stinson, FS, Dawson, DA, Chou, SP, Dufour, MC, Compton, W, Pickering, RP, Kaplan, K (2004 b). Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry 61, 807816.
Grella, CE, Karno, MP, Warda, US, Niv, N, Moore, AA (2009). Gender and co-morbidity among individuals with opioid use disorders in the NESARC study. Addictive Behaviors 34, 498504.
Hasin, D, Carpenter, KM, McCloud, S, Smith, M, Grant, BF (1997). The alcohol use disorder and associated disabilities interview schedule (AUDADIS): reliability of alcohol and drug modules in a clinical sample. Drug and Alcohol Dependence 44, 133141.
Hasin, DS, Goodwin, RD, Stinson, FS, Grant, BF (2005). Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Archives of General Psychiatry 62, 10971106.
Hatzenbuehler, ML, Keyes, KM, Narrow, WE, Grant, BF, Hasin, DS (2008). Racial/ethnic disparities in service utilization for individuals with co-occurring mental health and substance use disorders in the general population: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry 69, 11121121.
Haydon, E, Rehm, J, Fischer, B, Monga, N, Adlaf, E (2005). Prescription drug abuse in Canada and the diversion of prescription drugs into the illicit drug market. Canadian Journal of Public Health 96, 459461.
Huang, B, Dawson, DA, Stinson, FS, Hasin, DS, Ruan, WJ, Saha, TD, Smith, SM, Goldstein, RB, Grant, BF (2006). Prevalence, correlates, and comorbidity of nonmedical prescription drug use and drug use disorders in the United States: Results of the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry 67, 10621073.
Kendler, KS, Prescott, CA, Myers, J, Neale, MC (2003). The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Archives of General Psychiatry 60, 929937.
Krueger, RF, McGue, M, Iacono, WG (2001). The higher-order structure of common DSM mental disorders: internalization, externalization, and their connections to personality. Personality and Individual Differences 30, 12341259.
Kuehn, BM (2007). Prescription drug abuse rises globally. JAMA 297, 1306.
Lyons, M, Hitsman, B, Xian, H, Panizzon, MS, Jerskey, BA, Santangelo, S, Grant, MD, Rende, R, Eisen, S, Eaves, L, Tsuang, MT (2008). A twin study of smoking, nicotine dependence, and major depression in men. Nicotine and Tobacco Research 10, 97–108.
Martins, SS, Keyes, KM, Storr, CL, Zhu, H, Chilcoat, HD (2009 a). Pathways between nonmedical opioid use/dependence and psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug and Alcohol Dependence 103, 1624.
Martins, SS, Storr, CL, Zhu, H, Chilcoat, HD (2009 b). Correlates of extramedical use of Oxycontin® and other analgesic opioids among the US general population. Drug and Alcohol Dependence 99, 5867.
McCabe, SE, Cranford, JA, Boyd, CJ, Teter, CJ (2007). Motives, diversion and routes of administration associated with nonmedical use of prescription opioids. Addictive Behaviors 32, 562575.
Monheit, B (2010). Prescription drug misuse. Australian Family Physician 39, 541546.
Robinson, J, Sareen, J, Cox, BJ, Bolton, JM (2011). Role of self-medication in the development of comorbid anxiety and substance use disorders. Archives of General Psychiatry 68, 800806.
Saitoh, A, Kimura, Y, Suzuki, T, Kawai, K, Nagase, H, Kamei, J (2004). Potential anxiolytic and antidepressant-like activities of SNC80, a selective δ-opioid agonist, in behavioral models in rodents. Journal of Pharmacological Sciences 95, 374380.
Schepis, TS, Hakes, JK (2011). Non-medical prescription use increases the risk for the onset and recurrence of psychopathology: results from the National Epidemiological Survey on Alcohol and Related Conditions. Addiction. Published online: 1 June 2011. doi:10.1111/j.1360-0443.2011.03520.x.
Substance Abuse and Mental Health Services Administration Office of Applied Studies (2005). Results from the 2004 National Survey on Drug Use and Health: National Findings. DHHS publication no. SMA 05–4062, NSDUH series H-28. SAMHSA: Rockville, MD.
Substance Abuse and Mental Health Services Administration Office of Applied Studies (2006). Results from the 2005 National Survey on Drug Use and Health: National Health Findings. DHHS publication no. SMA 07–4293, NSDUH series H-32. SAMHSA: Rockville, MD.
Substance Abuse and Mental Health Services Administration (2009). Results from the 2008 National Survey on Drug Use and Health: National Findings. HHS publication no. SMA 09–4434, NSDUH series H-36. SAMHSA: Rockville, MD.
Substance Abuse and Mental Health Services Administration (2010). TEDS Report: Substance Abuse Treatment Admissions Involving Abuse of Pain Relievers: 1998 and 2008. SAMHSA: Rockville, MD.
Sullivan, ED, Edlund, MJ, Steffick, D, Unützer, J (2005). Regular use of prescribed opioids: association with common psychiatric disorders. Pain 119, 95–103.
Szklo, M, Javier-Nieto, F (2004). Quality assurance control. In Epidemiology: Beyond the Basics (ed. Sklo, M. and Javier Nieto, F.), p. 377. Jones and Bartlett Publishers: Sudbury, MA.
Tetrault, JM, Desai, RA, Becker, WC, Fiellin, DA, Concato, J, Sullivan, LE (2008). Gender and non-medical use of prescription opioids: results from a national US survey. Addiction 103, 258268.
Walwyn, WM, Miotto, KA, Evans, CJ (2010). Opioid pharmaceuticals and addiction: the issues, and research directions seeking solutions. Drug and Alcohol Dependence 108, 156165.
Weber, MM, Emrich, HM (1988). Current and historical concepts of opiate treatment in psychiatric disorders. International Clinical Psychopharmacology 3, 255266.
Young, SE, Smolen, A, Corley, RP, Krauter, KS, DeFries, JC, Crowley, TJ, Hewitt, JK (2002). Dopamine transporter polymorphism associated with externalizing behavior problems in children. American Journal of Medical Genetics 114, 144149.

Keywords

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed